A report from the Philadelphia Business Journal, this article shows off our new office space in Center City.Read More
This phase of the clinical trial will take between one and two months to complete, and will give doctors the ability to react quickly and adjust medical treatment for liver conditions based upon the results.
An interview by Tech Company News highlighting Group K Diagnostics and their recent fundraising successes.Read More
Out of 300 nominations, Brianna Wronko was selected as one of 35 women to comprise this year’s Women of Distinction class.Read More
Point-of-care diagnostic maker Group K Diagnostics has raised $2 million in Series A funding, the company announced yesterday. The new backing will mainly be used to expand the company’s lab infrastructure through new lab technician hires.Read More